 |
* Organisers: Manel Esteller; Co-ordinators: Silvia Marsoni and Miguel Angel Piris
* Venue: CNIO Auditorium
* Application Form (Registration fee 200 €)
Chair: M. Esteller, ES
Co-ordinators: S. Marsoni, IT - M.A. Piris, ES
MADRID
ABSTRACT SUBMISSION
Poster abstract deadline 15 SEPTEMBER 2007.
You may submit your abstract to the Organising Secretariat online at: www.cnio.es/meetings
Instructions for abstract submission
Participants with new data relevant to the subject of the conference may submit one abstract to
be considered for poster presentation. Only papers whose abstracts have been reviewed and
approved by the conference co-ordinator will be presented.
Abstracts should be written in English and the text should not exceed 2000 characters (or 450
words), title included.
The title should appear in capital letters.
For each author, type surname first, followed by first name and initials (presenting author in
capital letters).
List affiliations after the author's list.
Indicate 3-5 keywords at the end of the text.
The full address with telephone, fax number and email of the corresponding author must be
provided. This author will receive all the subsequent communication concerning this abstract.
Please also indicate your approval for publication in case the abstracts are issued in a journal.
Please note: Only abstracts submitted by registered participants will be accepted. Please do not
forget to mark on the registration form that you have submitted an abstract.
It is the responsibility of the presenting author to ascertain whether all authors are aware of the
content of the abstract before submission.
FACULTY
R. Agami, The Netherlands Cancer Institute, Amsterdam, NL
L. Altucci, Seconda Università degli Studi di Napoli, IT
A. Ashworth, Chester Beatty Laboratories, London, UK
R. Brown, Cancer Research UK Beatson Laboratories, Glasgow, UK
M. Esteller, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, ES
G. Garcia-Manero, The University of Texas, Houston, US
A.W. Griffioen, University Hospital Maastricht, NL
H. Hess-Stumpp, Schering AG, Berlin, DE
A. Imhof, University of Munich, DE
N.B. La Thangue, University of Oxford, UK
F. Lo Coco, Tor Vergara University, Rome, IT
M. Lubbert, University of Freiburg Medical Center, Freiburg, DE
F. Lyko, German Cancer Research Center, Heidelberg, DE
A. Mai, University of Rome La Sapienza, Rome, IT
V.E. Marquez, Center for Cancer Research, Frederick, US
S. Marsoni, SENDO, Milan, IT
S. Minucci, IFOM, Milan, IT
C. Nervi, University of Rome La Sapienza, Rome, IT
M.A. Piris, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, ES
V. Richon, Merck Research Laboratories, Boston, US
A. Zelent, Leukaemia Research Fund Centre at the Institute of Cancer Research (LRFC at ICR), London, UK
|
|
